Key result
Thoracoscopic LV lead implantation shows high safety with 0% in-hospital mortality or major complications.
Why the study?
Epicardial lead implantation is usually the second choice after failed coronary sinus cannulation for cardiac resynchronization therapy, but minimally invasive thoracoscopic lead implantation experience is limited.
Does minimally invasive surgical lead implantation using thoracoscopy provide safe and effective pacing in heart failure patients with failed coronary sinus cannulation?
Observational (n=17)
Does minimally invasive surgical lead implantation using thoracoscopy provide safe and effective pacing in heart failure patients with failed coronary sinus cannulation?
Thoracoscopic left ventricular lead implantation is a safe and feasible alternative for cardiac resynchronization therapy when coronary sinus cannulation fails.
Answers are grounded in this paper and cite their sources.
Thoracoscopic LV lead implantation may be feasible after failed CS cannulation; hypothesis-generating and requires prospective validation before wider use.
OBJECTIVE: Cardiac resynchronization therapy is a therapeutic option in patients with chronic heart failure. Epicardial lead implantation for biventricular pacing is usually the method of second choice after failed coronary sinus cannulation. The present study describes an initial experience with minimally invasive surgical lead implantation using thoracoscopy. METHODS: Since August 2008, a total of 17 patients (mean age 69.6 + 11.1 years) with congestive heart failure, NYHA functional class 3.1 +/- 0.4, and depressed ejection function (24.8% +/- 5.7%) were referred for surgery because of failed left ventricular lead implantation through the coronary sinus. Under single-lung ventilation and video-assisted thoracoscopy, epimyocardial steroid-eluting screw-in leads were implanted on the left ventricular free wall. RESULTS: There were no in-hospital deaths or major co-morbidities. The mean skin-to-skin operating time was 115.9 +/- 32.1 min, and the post-operative average length of stay was 8.4 +/- 2.5 days. Intraoperative acute threshold capture of the left ventricular lead was 0.88 +/- 0.54 V/0.5 ms, and the value of lead impedance was 434.7 +/- 110.8 Omega. Extension to a small thoracotomy was necessary in 1 patient to stop epicardial vein bleeding. CONCLUSION: Minimally invasive left ventricular lead implantation is a safe procedure with excellent acute threshold capture.
No takes yet. Share an insight, caveat, or question.
Pojar et al. (2011) conducted an observational in Congestive heart failure (n=17). Minimally invasive surgical lead implantation using thoracoscopy was evaluated on In-hospital deaths or major co-morbidities. Minimally invasive left ventricular lead implantation using thoracoscopy was safe, with 0% in-hospital deaths or major co-morbidities and an acute threshold capture of 0.88 V/0.5 ms.
Synapse has enriched 10 related papers. Consider them for comparative context: